Enter inventor name

Fort Worth, TX, United States of America

Jesse Albert May

This inventor holds 35 USPTO granted patents and 3 published patent applications, primarily in Glaucoma Treatment. Top assignees: Alcon, Inc., Alcon Laboratories, Inc., Alcon Manufacturing, Ltd.. Active years: 1992-2010.

USPTO Granted Patents = 35 (Patent Applications = 3)

% Patents Active = 45.7

Average Co-Inventor Count = 2.3

ph-index = 8

Forward Citations = 240(Granted Patents)

Location History:

Forth Worth, TX (US) (2007)
Fort Worth, TX (US) (1992 - 2010)

Company Filing History:

Alcon Laboratories, Inc.

patents

5 out of 81

Alcon Manufacturing, Ltd.

Yamanouchi Pharmaceutical Company Ltd.

patents

where one patent can have more than one assignee

Years Active: 1992-2010

Loading Chart...

Areas of Expertise:

Indazoles

Glaucoma

Carbonic Anhydrase Inhibitors

Sulfonamides

5ht2 Agonists

Dioxindoindazoles

Fused Indazoles

Pyranoindazoles

Aminoalkyl-Benzofuran

Ethacrynic Acid Compounds

Corneal Penetration

Intraocular Pressure

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7655662 - (Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating glaucoma and controlling intraocular pressure (2010-02-02),

2. 7476687 - Substituted furo[2,3-g]indazoles for the treatment of glaucoma (2009-01-13),

3. 7439262 - Substituted 1-alkylamino-1-H-indazoles for the treatment of glaucoma (2008-10-21),

4. 7425572 - Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma (2008-09-16),

5. 7338972 - Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma (2008-03-04),

6. 7297505 - Use of MDCK cell line to predict corneal penetration of drugs (2007-11-20),

7. 7285553 - [object Object] (2007-10-23),

8. 7268131 - Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma (2007-09-11),

9. 7129257 - Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma (2006-10-31),

10. 7060704 - [object Object] (2006-06-13),

11. 7012090 - Pyranoindoles for treating glaucoma (2006-03-14),

12. 7005448 - Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma (2006-02-28),

13. 7005443 - 5-Hydroxy indazole derivatives for treating glaucoma (2006-02-28),

14. 6989445 - Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma (2006-01-24),

15. 6960608 - Fused indazoles and indoles and their use for the treatment of glaucoma (2005-11-01),

Title: The Innovative Journey of Jesse Albert May

Introduction: Jesse Albert May, a pioneering inventor hailing from Fort Worth, TX, is a remarkable woman whose inventive spirit has led to groundbreaking creations in various fields.

Latest Patents: Jesse Albert May's latest patents include a cutting-edge technology for sustainable energy production and a revolutionary medical device aimed at improving patient care.

Career Highlights: Throughout her illustrious career, Jesse Albert May has been recognized for her innovative contributions, receiving multiple awards for her groundbreaking inventions. Her work has significantly impacted industries such as healthcare, technology, and environmental sustainability.

Collaborations: Jesse Albert May has collaborated with leading research institutions, universities, and companies to further develop and implement her inventions. Her collaborative efforts have resulted in the successful commercialization of several patented technologies.

Conclusion: Jesse Albert May's dedication to innovation and her passion for creating solutions to complex challenges have solidified her reputation as a trailblazing inventor. Her continued pursuit of excellence in the field of invention is an inspiration to aspiring innovators worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to [email protected]